Close

Publications

Gambia Pneumococcal Surveillance Group,; MACKENZIE, GA; Hill, PC; JEFFRIES, DJ; Ndiaye, M; Sahito, SM; Hossain, I; Uchendu, U; Ameh, D; Adeyemi, O; Pathirana, J; Olatunji, Y; Abatan, B; Muhammad, BS; Ahameefula, E; Fombah, AE; Adeshola, B; Lobga, BG; Saha, D; Mackenzie, R; Odutola, A; Plumb, ID; Akano, A; Ebruke, BE; Ideh, RC; ... Corrah, T.
2021
The Lancet. Infectious diseases, (2021).21 9 10.1016/S1473-3099(20)30880-X.
LIU, Y; SANDMANN, FG; BARNARD, RC; PEARSON, CA B; CMMID COVID-19 Working Group,; Pastore, R; Pebody, R; FLASCHE, S; JIT, M;
2021
Toor, J; Echeverria-Londono, S; Li, X; ABBAS, K; Carter, ED; Clapham, HE; CLARK, A; De Villiers, MJ; Eilertson, K; Ferrari, M; Gamkrelidze, I; Hallett, TB; Hinsley, WR; Hogan, D; Huber, JH; Jackson, ML; Jean, K; JIT, M; Karachaliou, A; KLEPAC, P; Kraay, A; Lessler, J; Li, X; Lopman, BA; Mengistu, T; ... Gaythorpe, KA.
2021
eLife, (2021).10, 10.7554/eLife.67635.
FONGWEN, N; Delrieu, I; Ham, LH; Gubler, DJ; Durbin, A; Ooi, E-E; PEELING, RW; FLASCHE, S; Hartigan-Go, K; CLIFFORD, S; Martinez, CT; De Lamballerie, X; Barnighausen, T; WILDER-SMITH, A;
2021
Vaccine, (2021).39 34 10.1016/j.vaccine.2021.06.083.
Loomba, S; De Figueiredo, A; Piatek, SJ; De Graaf, K; LARSON, HJ;
2021
Nature human behaviour, (2021).5 7 10.1038/s41562-021-01172-y.
Drolet, M; Laprise, J-F; Martin, D; JIT, M; Bénard, É; Gingras, G; Boily, M-C; Alary, M; Baussano, I; Hutubessy, R; Brisson, M;
2021
The Lancet. Infectious diseases, (2021).21 11 10.1016/S1473-3099(20)30860-4.
GLYNN, JR; Dube, A; FIELDING, K; CRAMPIN, AC; Karonga Prevention Trial Group,; Kanjala, C; FINE, PE M;
2021
The Lancet. Infectious diseases, (2021).21 11 10.1016/S1473-3099(20)30994-4.
Simulation results for "COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness".
PEARSON, CA B; BOZZANI, F; PROCTER, SR; DAVIES, NG; Huda, M; JENSEN, HT; KEOGH-BROWN, M; Khalid, M; SWEENEY, S; TORRES-RUEDA, S; EGGO, RM; VASSALL, A; JIT, M;
2021
, Zenodo (2021).
Replication Data for: Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors.
Uyoga, S; ADETIFA, IM O; OTIENDE, M; Gitonga, JN; Mugo, D; Nyagwange, J; Karanja, HK; Tuju, J; Makale, J; Aman, R; Mwangangi, M; Amoth, P; Kasera, K; Ng'ang'a, W; Chege, E; Yegon, C; Kithi, K; Odhiambo, E; Rotich, T; Orgut, I; Kihara, S; BOTTOMLEY, C; Kagucia, EW; GALLAGHER, KE; Etyang, A; ... SCOTT, JA G.
2021
, Harvard Dataverse (2021).